Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
for Chronic Neuropathic Pain
Sites in La Jolla +10 more locations
Sponsor: Sangamo Therapeutics
Sex: All·Age: 18+
Code: NCT06980948·Phase 1, Phase 2·Recruiting·Listed May 2025